Encompass Health [EHC] vs Ensign Group [ENSG] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 21 vital metrics comparison: Encompass Health Corporation wins in 17 metrics, Ensign Group, Inc. wins in 4 metrics, with 0 ties. Encompass Health Corporation appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Encompass Health Corporation | Ensign Group, Inc. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 18.52 | 32.78 | Encompass Health Corporation |
| Price-to-Book Ratio | 4.21 | 4.95 | Encompass Health Corporation |
| Debt-to-Equity Ratio | 82.85 | 98.70 | Encompass Health Corporation |
| PEG Ratio | 0.89 | 1.76 | Encompass Health Corporation |
| EV/EBITDA | 9.92 | 24.01 | Encompass Health Corporation |
| Profit Margin (TTM) | 9.54% | 6.80% | Encompass Health Corporation |
| Operating Margin (TTM) | 18.35% | 9.10% | Encompass Health Corporation |
| EBITDA Margin (TTM) | 18.35% | 9.10% | Encompass Health Corporation |
| Return on Equity | 24.82% | 16.90% | Encompass Health Corporation |
| Return on Assets (TTM) | 9.66% | 5.25% | Encompass Health Corporation |
| Free Cash Flow (TTM) | $439.20M | $370.71M | Encompass Health Corporation |
| Dividend Yield | 0.68% | 0.16% | Encompass Health Corporation |
| 1-Year Return | -16.09% | -1.24% | Ensign Group, Inc. |
| Price-to-Sales Ratio (TTM) | 1.74 | 2.21 | Encompass Health Corporation |
| Enterprise Value | $13.70B | $12.70B | Encompass Health Corporation |
| EV/Revenue Ratio | 2.31 | 2.51 | Encompass Health Corporation |
| Gross Profit Margin (TTM) | 95.82% | 16.34% | Encompass Health Corporation |
| Revenue per Share (TTM) | $59 | $88 | Ensign Group, Inc. |
| Earnings per Share (Diluted) | $5.55 | $5.85 | Ensign Group, Inc. |
| Beta (Stock Volatility) | 0.60 | 0.82 | Encompass Health Corporation |
| Short % of Float | 3.81% | 2.93% | Ensign Group, Inc. |
Encompass Health Corporation vs Ensign Group, Inc. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Encompass Health Corporation | -2.08% | -1.73% | -6.83% | -2.04% | -7.65% | -6.59% |
| Ensign Group, Inc. | 0.90% | -3.65% | -15.17% | -28.05% | -14.90% | -13.35% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Encompass Health Corporation | -16.09% | 55.92% | 60.05% | 221.72% | 399.85% | 545.89% |
| Ensign Group, Inc. | -1.24% | 57.98% | 79.14% | 733.07% | 1,721.59% | 3,525.49% |
Performance & Financial Health Analysis: Encompass Health Corporation vs Ensign Group, Inc.
| Metric | EHC | ENSG |
|---|---|---|
| Market Information | ||
| Market Cap | $10.25B | $11.06B |
| Market Cap Category | Large cap | Large cap |
| 10 Day Avg. Volume | 858,260 | 313,976 |
| 90 Day Avg. Volume | 939,637 | 348,765 |
| Last Close | $99.36 | $150.71 |
| 52 Week Range | $92.77 - $127.99 | $134.79 - $218.00 |
| % from 52W High | -22.37% | -30.87% |
| All-Time High | $127.99 (Oct 24, 2025) | $218.00 (Mar 02, 2026) |
| % from All-Time High | -22.37% | -30.87% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.10% | 0.20% |
| Quarterly Earnings Growth | 0.21% | 0.20% |
| Financial Health | ||
| Profit Margin (TTM) | 0.10% | 0.07% |
| Operating Margin (TTM) | 0.18% | 0.09% |
| Return on Equity (TTM) | 0.25% | 0.17% |
| Debt to Equity (MRQ) | 82.85 | 98.70 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $24.38 | $38.71 |
| Cash per Share (MRQ) | $0.73 | $9.92 |
| Operating Cash Flow (TTM) | $1.18B | $564.27M |
| Levered Free Cash Flow (TTM) | $296.79M | $281.25M |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.68% | 0.16% |
| Last 12-Month Dividend | $0.72 | $0.32 |
Valuation & Enterprise Metrics Analysis: Encompass Health Corporation vs Ensign Group, Inc.
| Metric | EHC (Apr 23, 2026) | ENSG (Apr 24, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 18.52 | 32.78 |
| Forward P/E | 15.86 | 23.27 |
| PEG Ratio | 0.89 | 1.76 |
| Price to Sales (TTM) | 1.74 | 2.21 |
| Price to Book (MRQ) | 4.21 | 4.95 |
| Market Capitalization | ||
| Market Capitalization | $10.25B | $11.06B |
| Enterprise Value | $13.70B | $12.70B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.31 | 2.51 |
| Enterprise to EBITDA | 9.92 | 24.01 |
| Risk & Other Metrics | ||
| Beta | 0.60 | 0.82 |
| Book Value per Share (MRQ) | $24.38 | $38.71 |
Financial Statements Comparison: Encompass Health Corporation vs Ensign Group, Inc.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | EHC (2025) | ENSG (2025) |
|---|---|---|
| Revenue/Sales | 5.94B | 5.06B |
| Cost of Goods Sold | 254.40M | 4.26B |
| COGS % of Revenue | 4.3% | 84.2% |
| Gross Profit | 5.68B | 799.45M |
| Gross Margin | 95.7% | 15.8% |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | 1.05B | 425.31M |
| Operating Margin | 17.7% | 8.4% |
| EBITDA | 1.40B | 567.94M |
| EBITDA Margin | 23.7% | 11.2% |
| Pre-Tax Income | 953.00M | 455.62M |
| Pre-Tax Income % of Revenue | 16.1% | 9.0% |
| Income Tax | 192.90M | 111.36M |
| Income Tax % of Revenue | 3.3% | 2.2% |
| Net Income (Profit) | 759.10M | 344.26M |
| Profit Margin | 12.8% | 6.8% |
Balance Sheet & Liquidity Metrics
| Metric | EHC (2025) | ENSG (2025) |
|---|---|---|
| Cash & Equivalents | 72.20M | 503.88M |
| Total Current Assets | 905.90M | 1.27B |
| Total Current Assets % of Revenue | 15.3% | 25.2% |
| Total Current Liabilities | 836.40M | 894.35M |
| Total Current Liabilities % of Revenue | 14.1% | 17.7% |
| Long-Term Debt | 2.64B | 2.09B |
| Long-Term Debt % of Revenue | 44.5% | 41.3% |
| Total Shareholders Equity | 3.28B | 2.23B |
| Retained Earnings | 1.29B | 1.76B |
| Retained Earnings % of Revenue | 21.7% | 34.7% |
| Property, Plant & Equipment | 212.60M | 2.58B |
Cash Flow Statement Comparison
| Metric | EHC (2025) | ENSG (2025) |
|---|---|---|
| Operating Cash Flow | 1.19B | 409.74M |
| Operating Cash Flow % of Revenue | 20.1% | 8.1% |
| Capital Expenditures | -736.40M | -193.56M |
| Free Cash Flow | 439.20M | 370.71M |
| FCF Margin | 7.4% | 7.3% |
| Debt Repayment | -239.00M | -4.09M |
| Common Stock Repurchase | -158.00M | -21.43M |
Short Interest & Institutional Ownership Analysis
| Metric | EHC | ENSG |
|---|---|---|
| Shares Short | 3.36M | 1.44M |
| Short Ratio | 3.73 | 4.15 |
| Short % of Float | 3.81% | 2.93% |
| Shares Outstanding | 100.00M | 58.09M |
| Float Shares | 98.16M | 55.59M |
| % Held by Insiders | 1.05% | 3.54% |
| % Held by Institutions | 102.10% | 93.84% |
| % Held by Public | -3.15% | 2.62% |
Dividend Analysis & Yield Comparison: Encompass Health Corporation vs Ensign Group, Inc.
| Metric | EHC | ENSG |
|---|---|---|
| Last 12-Month Dividend | $0.72 | $0.32 |
| Last 12-Month Dividend Yield | 0.68% | 0.16% |
| 3-Year Avg Annual Dividend | $0.65 | $0.27 |
| 3-Year Avg Dividend Yield | 0.19% | 0.05% |
| 3-Year Total Dividends | $1.96 | $0.80 |
| Ex-Dividend Date | Jan 02, 2026 | Mar 31, 2026 |